Cortagen research in Canada investigates the cardioprotective and vascular epigenetic regulatory properties of this short bioregulatory peptide. Cortagen (Ala-Glu-Asp-Gly, AEDG) is a tetrapeptide derived from cardiac and vascular tissue that belongs to the Khavinson family of short regulatory peptides. Canadian cardiovascular biology researchers study Cortagen for its effects on cardiomyocyte gene expression, collagen synthesis regulation in cardiac fibroblasts, and vascular tissue aging biology in research models.
Cardiac Epigenetics Research
Cortagen is hypothesized to enter cardiomyocyte nuclei and interact with chromatin to regulate the expression of genes involved in cardiac muscle function and maintenance. Canadian cardiovascular epigenetics researchers study how this short tetrapeptide sequence influences histone methylation and acetylation states in cardiac tissue models, potentially modulating genes involved in myosin expression, calcium handling, and mitochondrial biogenesis.
Vascular Biology and Aging Research
The vascular endothelium undergoes significant epigenetic changes with aging that affect vasoprotective gene expression. Canadian vascular biology researchers study Cortagen to understand how cardiac-derived peptide bioregulators influence endothelial cell gene expression patterns and whether they can restore youthful vascular biology signatures in aged cell culture models.
Sourcing Cortagen in Canada
Research-grade Cortagen is available in Canada from EhBuddy Peptides. Lab-tested for purity. For laboratory research use only.
Cortagen adds cardiovascular tissue specificity to the Khavinson bioregulator toolkit, offering Canadian heart biology researchers a targeted epigenetic research tool for cardiac and vascular aging science.
